Repulsive Axon Guidance by Draxin Is Mediated by Protein Kinase B (Akt), Glycogen Synthase Kinase-3β (GSK-3β) and Microtubule-Associated Protein 1B

被引:18
|
作者
Meli, Rajeshwari [1 ]
Weisova, Petronela [1 ]
Propst, Friedrich [1 ]
机构
[1] Univ Vienna, Vienna Bioctr VBC, Dept Biochem & Cell Biol, MFPL, A-1030 Vienna, Austria
来源
PLOS ONE | 2015年 / 10卷 / 03期
关键词
GROWTH-CONE COLLAPSE; NETRIN RECEPTOR DCC; NEURONAL MIGRATION; PHOSPHATIDYLINOSITOL; 3-KINASE; MAP1B; PHOSPHORYLATION; MECHANISM; OUTGROWTH; INHIBITION; INSULIN;
D O I
10.1371/journal.pone.0119524
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Draxin is an important axon guidance cue necessary for the formation of forebrain commissures including the corpus callosum, but the molecular details of draxin signaling are unknown. To unravel how draxin signals are propagated we used murine cortical neurons and genetic and pharmacological approaches. We found that draxin-induced growth cone collapse critically depends on draxin receptors (deleted in colorectal cancer, DCC), inhibition of protein kinase B/Akt, activation of GSK-3 beta (glycogen synthase kinase-3 beta) and the presence of microtubule-associated protein MAP1B. This study, for the first time elucidates molecular events in draxin repulsion, links draxin and DCC to MAP1B and identifies a novel MAP1B-depenent GSK-3 beta pathway essential for chemo-repulsive axon guidance cue signaling.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
    Medina, Miguel
    Avila, Jesus
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (25) : 2790 - 2798
  • [32] Glycogen synthase kinase-3 (GSK-3) expression in prostate cancer with perineural invasion
    Li, R.
    Dai, H.
    Wheeler, T. M.
    Ayala, G. E.
    LABORATORY INVESTIGATION, 2007, 87 : 159A - 160A
  • [33] Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Ala pathway in gliomas
    Atkins, Ryan J.
    Dimou, James
    Paradiso, Lucy
    Morokoff, Andrew P.
    Kaye, Andrew H.
    Drummond, Katharine J.
    Hovens, Christopher M.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (11) : 1558 - 1563
  • [34] Glycogen synthase kinase-3 (GSK-3) expression in prostate cancer with perineural invasion
    Li, R.
    Dai, H.
    Wheeler, T. M.
    Ayala, G. E.
    MODERN PATHOLOGY, 2007, 20 : 159A - 160A
  • [35] The role of glycogen synthase kinase-3β (GSK-3β) signaling in dendrite initiation and growth
    Naska, S.
    Park, K.
    Miller, F.
    Kaplan, D.
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2006, 24 (08) : 576 - 576
  • [36] Mechanical unloading of the failing human heart fails to activate the protein kinase B/Akt/glycogen synthase kinase-3β survival pathway
    Razeghi, P
    Bruckner, BA
    Sharma, S
    Youker, KA
    Frazier, OH
    Taegtmeyer, H
    CARDIOLOGY, 2003, 100 (01) : 17 - 22
  • [37] Downregulation of glycogen synthase kinase-3β (GSK-3β) protein expression during neuroblastoma IMR-32 cell differentiation
    Muñoz-Moñtano, JR
    Moreno, FJ
    Avila, J
    Díaz-Nido, J
    JOURNAL OF NEUROSCIENCE RESEARCH, 1999, 55 (03) : 278 - 285
  • [38] Glycogen Synthase Kinase-3β (GSK-3β) and Nuclear Factor Kappa-B (NFKB) in Childhood Acute Lymphoblastic Leukemia
    Layton Tovar, Cristian Fabian
    Mendieta Zeron, Hugo
    Camarillo Romero, Maria del Socorro
    Fabila Sanchez, Yanko V.
    Tejocote Romero, Isidoro
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 25 (06): : 1139 - 1147
  • [39] 6-aryl-pyrazolo[3,4-b]pyridines:: Potent inhibitors of glycogen synthase kinase-3 (GSK-3)
    Witherington, J
    Bordas, V
    Gaiba, A
    Garton, NS
    Naylor, A
    Rawlings, AD
    Slingsby, BP
    Smith, DG
    Takle, AK
    Ward, RW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (18) : 3055 - 3057
  • [40] 5-aryl-pyrazolo[3,4-b]pyridazines:: Potent inhibitors of glycogen synthase kinase-3 (GSK-3)
    Witherington, J
    Bordas, V
    Haigh, D
    Hickey, DMB
    Ife, RJ
    Rawlings, AD
    Slingsby, BP
    Smith, DG
    Ward, RW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (09) : 1581 - 1584